Certainly an interesting article GG
most of the issues seem to be in the Bios which are in the early stages of development or don't even have a drug being trialled
PAR is a long way down the track
What I did find exciting is the comment that Pharmas have cash of around $1.2 trillion available to spend on partnerships etc.
Certainly an interesting article GGmost of the issues seem to be...
-
- There are more pages in this discussion • 1,719 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.015(5.77%) |
Mkt cap ! $85.80M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.0¢ | 24.0¢ | $969.3K | 3.648M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 34182 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 24689 | 1 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |